Ourania Tatsis - Aug 9, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Reg. & Quality Off.
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Aug 9, 2022
Transactions value $
-$418,557
Form type
4
Date filed
8/10/2022, 04:06 PM
Previous filing
Mar 21, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$86.9K -292 -0.61% $297.54 47.2K Aug 9, 2022 Direct F1, F2, F3, F4
transaction VRTX Common Stock Sale -$203K -679 -1.44% $298.77 46.5K Aug 9, 2022 Direct F2, F3, F5
transaction VRTX Common Stock Sale -$84.8K -283 -0.61% $299.79 46.2K Aug 9, 2022 Direct F2, F3, F6
transaction VRTX Common Stock Sale -$21.6K -72 -0.16% $300.64 46.2K Aug 9, 2022 Direct F2
transaction VRTX Common Stock Sale -$22.3K -74 -0.16% $301.67 46.1K Aug 9, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 134 shares previously purchased under the issuer's Employee Stock Purchase Plan.
F2 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
F3 Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $297.54 (range $297.00 to $297.80).
F5 Open market sales reported on this line occurred at a weighted average price of $298.77 (range $298.29 to $299.19).
F6 Open market sales reported on this line occurred at a weighted average price of $299.79 (range $299.44 to $300.33).